BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7544154)

  • 1. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy.
    Greenhalgh DA; Wang XJ; Eckhardt JN; Roop DR
    Cell Growth Differ; 1995 May; 6(5):579-86. PubMed ID: 7544154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
    Wang XJ; Greenhalgh DA; Roop DR
    Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between v-fos and v-rasHA induces autonomous papillomas in transgenic epidermis but not malignant conversion.
    Greenhalgh DA; Quintanilla MI; Orengo CC; Barber JL; Eckhardt JN; Rothnagel JA; Roop DR
    Cancer Res; 1993 Nov; 53(21):5071-5. PubMed ID: 7693330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
    Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
    Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas.
    Wang XJ; Greenhalgh DA; Lu XR; Bickenbach JR; Roop DR
    Oncogene; 1995 Jan; 10(2):279-89. PubMed ID: 7530825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
    Rutberg SE; Adams TL; Glick A; Bonovich MT; Vinson C; Yuspa SH
    Cancer Res; 2000 Nov; 60(22):6332-8. PubMed ID: 11103794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperplasia, hyperkeratosis and benign tumor production in transgenic mice by a targeted v-fos oncogene suggest a role for fos in epidermal differentiation and neoplasia.
    Greenhalgh DA; Rothnagel JA; Wang XJ; Quintanilla MI; Orengo CC; Gagne TA; Bundman DS; Longley MA; Fisher C; Roop DR
    Oncogene; 1993 Aug; 8(8):2145-57. PubMed ID: 7687760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation between Ha-ras and fos or transforming growth factor alpha overcomes a paradoxic tumor-inhibitory effect of p53 loss in transgenic mouse epidermis.
    Wang XJ; Greenhalgh DA; Donehower LA; Roop DR
    Mol Carcinog; 2000 Oct; 29(2):67-75. PubMed ID: 11074603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression.
    Wang XJ; Greenhalgh DA; Eckhardt JN; Rothnagel JA; Roop DR
    Mol Carcinog; 1994 May; 10(1):15-22. PubMed ID: 8185825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice expressing targeted HPV-18 E6 and E7 oncogenes in the epidermis develop verrucous lesions and spontaneous, rasHa-activated papillomas.
    Greenhalgh DA; Wang XJ; Rothnagel JA; Eckhardt JN; Quintanilla MI; Barber JL; Bundman DS; Longley MA; Schlegel R; Roop DR
    Cell Growth Differ; 1994 Jun; 5(6):667-75. PubMed ID: 7522035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
    Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
    Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
    Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation.
    Rodríguez-Villanueva J; Greenhalgh D; Wang XJ; Bundman D; Cho S; Delehedde M; Roop D; McDonnell TJ
    Oncogene; 1998 Feb; 16(7):853-63. PubMed ID: 9484776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.